News
British-Swedish drug maker has gone from Beijing’s scrutiny to its praise, hailed as a sign of doing business in China.
AstraZeneca's chairman Leif Johansson, is one of Sweden's leading industrialists, a former president and CEO of the country's iconic automotive firm Volvo, and also currently chairman of telecoms ...
It was under the long-serving CEO, Borje Gabrielsson ... disease (GERD), was first launched in Sweden. Between 2001 and 2005, Nexium netted AstraZeneca approximately $14.4 billion.
The shareholders of Cantargia AB (publ) are invited to the annual general meeting on Thursday, 15 May 2025, at 15.00 CEST at Ideon ...
Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...
Hosted on MSN22d
AstraZeneca expands in China with a $2.5B investment in Beijingand our continued commitment to China,” CEO Pascal Soriot said. Concurrently, AstraZeneca (NASDAQ:AZN) announced collaboration and licensing agreements with biotechs Harbour BioMed and Syneron ...
Pascal Soriot, global CEO of AstraZeneca, said in an exclusive interview with China Daily that the company is investing more in research and development in the world's second-largest economy ...
Assemblin has been tasked with an upgrade of AstraZeneca's Gärtuna production plant in Södertälje, Sweden. The project entails multi-technical installations and general construction ...
Billionaire Dalio, head of the world's largest hedge fund, is considered a global authority on investing in China. The bank was the first to set up a wholly foreign-owned securities firm in China when ...
AstraZeneca has entered the “off-the-shelf ... Belgium-based Esobiotech is a relatively new entrant in the space, with CEO Jean-Pierre Latere, Ph.D., explaining on the call that the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results